Scotland · NHS Scotland MSAN
Sancuso® (granisetron) 3.1mg/24 hours transdermal
MSAN(2021)7 · Level 2 · issued 08 Mar 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Sancuso® (granisetron) 3.1mg/24 hours transdermal patches are out of stock until late March | Out of stock | late March |
| 3. An alternative 5HT3 antagonist, ondansetron, is available in formulations suitable for patients | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.